Immediate Impact
2 from Science/Nature 50 standout
Citing Papers
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of T. Kumke being referenced
OP0108 DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAÏVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY
2019
LB0001 Dual neutralisation of il-17a and il-17f with bimekizumab in patients with active ankylosing spondylitis (AS): 12-week results from a phase 2b, randomised, double-blind, placebo-controlled, dose-ranging study
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| T. Kumke | 82 | 53 | 115 | 86 | 49 | 369 | |
| Zhenrui Cao | 6 | 22 | 19 | 74 | 26 | 377 | |
| Zhihua Tu | 41 | 35 | 24 | 54 | 25 | 327 | |
| Shyam K. Nair | 10 | 23 | 22 | 83 | 27 | 314 | |
| Yuan Gao | 11 | 8 | 47 | 41 | 30 | 410 | |
| Jiaxin Zhou | 82 | 3 | 111 | 29 | 21 | 350 | |
| Qiaoling Guo | 14 | 28 | 30 | 47 | 21 | 322 | |
| Yanbin He | 4 | 9 | 66 | 77 | 28 | 363 | |
| Jiacun Chen | 4 | 17 | 30 | 64 | 33 | 374 | |
| Annette Bolton | 3 | 4 | 149 | 105 | 20 | 340 | |
| Arindam Chakraborty | 2 | 6 | 84 | 76 | 39 | 327 |
All Works
Loading papers...